Back to Ghanta Home Page

Vithal K. Ghanta

Education:

Positions Held:

Publications:

Ghanta, V., N.M. Hamlin, T.G. Pretlow and R.N. Hiramoto. 1972. Use of dextran conjugated SRBC for the detection of MOPC 104E tumor cells. J. Immunol. 109:810.

BeMiller, J.N. and V.K. Ghanta. 1972. Beta-elimination in uronic acids: Evidence for ElcB mechanism. Carbohyd. Res. 25:419.

BeMiller, J.N., V.K. Ghanta and S.D. Darling. 1972. Oxidation of carbohydrates with ferrate VI ion. Tetrahedron Lett. No. 40, 4143.

Hiramoto, R., V.K. Ghanta, J.R. McGhee, R. Schrohenloher and N.M. Hamlin. 1972. Use of dextran conjugated column for the isolation of large quantities of MOPC 104E IgM. Immunochemistry 9:1251.

Ghanta, V.K., N.M. Hamlin and R.N. Hiramoto. 1973. Use of fluorescein conjugated dextran for the detection of MOPC 104E cells. Immunochemistry 10:51.

Hiramoto, R.N., E.L. Smith, V.K. Ghanta, J.F. Shaw and J.M. McKibben. 1973. Intestinal glycolipids with blood group activity. J. Immunol. 110:1037.

Hiramoto, R.N. and V.K. Ghanta. 1973. Studies of MOPC 104E plasmacytoma cells forming rosettes with autologous and syngeneic erythrocytes. J. Immunol. 111:893.

Ghanta, V.K., J.R. McGhee and R.N. Hiramoto. 1973. A modified immunofluorescence technique for detection of surface Ig. Proc, Soc. Exp. Biol. Med. 144:225.

Ghanta, V.K., J.R. McGhee, S-J. Soong, N.M. Hamlin, D.C. Hurst and R.N.Hiramoto. 1973. A study of the single radial hemolysis in gel system. III. Quantitation of complement. Immunochemistry 10:645.

Hiramoto, R.N., V.K. Ghanta, J.R. McGhee and N.M. Hamlin. 1973. A mathematical model for the quantitation of tumor and antibody forming cell populations within an animal's body. J. Immunol. 111:1546.

McGhee, J.R., S.M. Michalek and V.K. Ghanta. 1974. Detection and quantitation of rat milk complement. IRCS 2:1120.

McGhee, J.R., S.M. Michalek, V.K. Ghanta and G. Stewart. 1974. Complement levels in malnourished animals. I. Quantitation of serum complement in rat dams and their offspring. J. Reticuloendothel. Soc. 16:204.

Michalek, S.M., J.R. McGhee and V.K. Ghanta. 1974. Complement levels in malnourished animals. Measurement of complement in rat milk during period of lactation. J. Reticuloendothel. Soc. 16:213.

BeMiller, J.N., D.R. Smith, V.K. Ghanta, T.O. Lyles and E.R. Doyle. 1974. Acid-catalyzed hydrolysis of maltose and cellobiose 1-phenylflavazoles. Carbohyd. Res. 35:244.

Ghanta, V.K., J.R. McGhee, N.M. Hamlin and R.N. Hiramoto. 1974. Measurement of antibody release from single cells. III. Rate of release of IgM from MOPC 104E plasmacytoma. J. Immunol. 112:266.

Ghanta, V.K. and R.N. Hiramoto. 1974. Quantitation of total body tumor cells (MOPC 104E). I. Subcutaneous tumor model. J. Nat. Cancer Inst. 52:1199.

Ghanta, V.K. and R.N. Hiramoto. 1974. Quantitation of antigens by immunoelectrophoresis. Immunochemistry 11:305.

Hiramoto, R.N. and V.K. Ghanta. 1974. Chemotherapy and rate of kill of tumor cells in a mouse plasmacytoma. Cancer Res. 34:1738.

Hiramoto, R.N., V.K. Ghanta and N.M. Hamlin. 1974. Quantitation of total body tumor cells (MOPC 104E). II. Ascites tumor model. J. Nat. Cancer Inst. 53:767.

Hiramoto, R.N., V.K. Ghanta and J.R. Durant. 1975. Evaluation of a cooperative group human myeloma protocol using the MOPC 104E myeloma model. Cancer Res. 35:1309.

McGhee, J.R., S.M. Michalek and V.K. Ghanta. 1975. Rat immunoglobulins in serum and secretions. Purification of rat IgM, IgA and IgG and their quantitation in serum, colostrum, milk and saliva. Immunochemistry 12:817.

Ghanta, V., R. Hiramoto, A. Weiss and L. Caudill. 1976. Monitoring murine osteosarcoma by serial alkaline phosphatase determinations. J. Nat. Cancer Inst. 57:837.

Barnhill, C.W., V.K. Ghanta, R.N. Hiramoto and K.L. Yielding. 1976. Immunologic suppression of DNA synthesis in MOPC 104E plasmacytoma cells. Proc. Soc. Exp. Biol. Med. 153:107-111.

Lamon, E.W., B. Andersson, H.D. Whitten, M.M. Hurst and V. Ghanta. 1976. IgM complex receptors on subpopulations of murine lymphocytes. J. Immunol. 116:1199.

Hiramoto, R., V. Ghanta, S-J. Soong and D. Hurst. 1977. An experimental approach to relate a tumor associated enzyme marker to tumor cell numbers. Cancer Res. 37:771-774.

Ghanta, V., M.T. Jones, D. Woodard, J.R. Durant and R. Hiramoto. 1977. Cisdichlorodiammineplatinum (II) in experimental cancer chemotherapy. Cancer Res. 37:771-774.

Ghanta, V., R. Hiramoto and M.H. Durant. 1978. Age dependent reaction of mouse thymus cells with autologous and syngeneic erythrocytes. Mech. Aging Develop. 8:329.

Ghanta, V., R. Hiramoto, A.B. Weiss, L. Caudill and D.W. Davis. 1978. Tumor immunology of experimental osteosarcoma. Clin. Orthopaed. and Related Res. 133:246-260.

Durkin, W., V. Ghanta, C. Balch, D. Davis and R. Hiramoto. 1979. A methodologic approach to predict anti-cancer drug effect in man. Cancer Res. 39:402.

Ghanta, V., R. Hiramoto, D. Davis, S-J. Soong, D. Hurst and L. Hsu. 1979. Sequential appearance of auto-erythrocyte antibody Ig classes with age. J. Gerontol. 34:177-182.

Hiramoto, R., V. Ghanta, L. Hsu and D. Davis. 1979. Age-related changes in auto-erythrocyte resettes in the C57BL/6J and NZB/NIHJ mice. Mech. Aging Develop. 11:45-54.

Hiramoto, R.N. and V.K. Ghanta. 1980. Surgical adjuvant chemotherapy of metastatic murine osteosarcoma. Int. J. Cancer 25:393-397.

Ghanta, V.K., R.N. Hiramoto, D.W. Davis and N.S. Hiramoto. 1980. Maintenance of MOPC 104E myeloma in the plateau phase. Cancer Res. 40:2372-376.

Ghanta, V.K., S-J. Soong, D.C. Hurst and R.N. Hiramoto. 1980. Osteosarcoma associated alkaline phosphatase and in vivo growth and development. Proc. Soc. Exp. Biol. Med. 164:229-233.

Hiramoto, R., V. Ghanta, J.R. Durant and N. Hiramoto. 1980. A murine plasmacytoma model for screening active drugs for human myeloma. Cancer Clin. Trials 3:395-402.

Hsu, K-H.L., V.K. Ghanta, L.A. Duncan, C.E. Hunt and R.N. Hiramoto. 1980. Characterization of an auto-rosette inhibitory fraction in mouse serum. J. Immunol. 125:1298-1301.

Ghanta, V.K., H.J. Cohen, H.R. Silberman J.R. Durant and R.N. Hiramoto, R.N. 1981. Assessment of myeloma maintenance regimen of prednisone, adriamycin, imuran and vincristine in a murine plasmacytoma model. Cancer Clin. Trials 4:135-141.

Hsu, K-H.L., V.K. Ghanta and R.N. Hiramoto. 1981. Immunosuppresive effect of mouse serum lipoproteins. I. In vitro studies. J. Immunol. 126:1909.

Ghanta, V.K., N.S. Hiramoto, and R.N. Hiramoto. 1981. Effect of immune response to sheep red blood cells on MOPC 104E plasmacytoma. Cancer Res. 41:2197-2199.

Kikuchi, Y., T. Miura, R.T. Parmley, V. Ghanta and R. Hiramoto. 1982. Inhibitory effect of L-homoarginine on murine osteosarcoma cell proliferation. Cancer Res. 42:1072-1077.

Kikuchi, Y., R. Hiramoto and V. Ghanta. 1982. Mitogen response of peripheral blood and spenic lymphocytes of tumor-bearing mice. Cancer Immunol. Immunother. 12:225-230.

Hsu, K-H.L., R.N. Hiramoto and V.K. Ghanta. 1982. Immunosuppressive effect of mouse serum lipoproteins. II. In vivo studies. J. Immunol. 128:2107.

Ng, T., W. Evanochko, R. Hiramoto, V. Ghanta, M. Lilly, A. Lawson, T. Corbett, J. Durant and J. Glickson. 1982. 31P topical NMR spectroscopy of in vivo tumors. J. Mag. Resonance 49:271-286.

Golczewski, J.A., R.N. Hiramoto and V.K. Ghanta. 1982. Antigenic determinants on lymphocytes from young and old C57BL/6 mice. Exp. Gerontol. 17(5):375-381.

Golczewski, J.A., R.N. Hiramoto and V.K. Ghanta. 1982. Enhancement of maze learning in old C57BL/6 mice by dietary lecithin. Neurobiol. Aging 3:223-226.

Hiramoto, R.N. and V.K. Ghanta. 1983. Investigation in the role of surgery, chemotherapy and radiation in a murine osteosarcoma model. Amer. J. Clin. Oncol. 6:61-69.

Ghanta, V.K., P.J. Noble, M.E. Brown, P.J. Cox, N.F. Hiramoto. 1983. Alloreactivity. I. Effects of age and thymic hormone treatment on cell-mediated immunity in C57BL/6NNia mice. Mech. Aging Develop. 22:309-319.

Miura, T., R.N. Hiramoto and V.K. Ghanta. 1983. MOPC 104E plasmacytoma functional heterogeneity and maturational potential in culture. Cancer Res. 43:953-958.

Ghanta, V.K., K. Shrestha, J.R. Durant and R.N. Hiramoto. 1983. Tumor proliferation and chemotherapy in immunosuppressed mice. Cancer Res. 43:1097-1100.

Lilly, M., T. Ng, W. Evanochko, C. Katholi, N. Kumar, G. Elgavish, J. Durant, J. R. Hiramoto, V. Ghanta and J. Glickson. 1984. Loss of high-energy phosphate following hyperthermia combined with cyclophosphamide. Cancer Res. 44:1405-1408.

Dean, D., R. Hiramoto, V. Ghanta, N. Hiramoto and C. Wall. 1984. Effect of orchiectomy on spleen cell mitogen response and on the thymus of aged mice. Exp. Aging Res. 10:189-191.

Hiramoto, R.N., V.K. Ghanta and M.B. Lilly. 1984. Reduction of tumor burden in a murine osteosarcoma following hyperthermia combined with cyclophosphamide. Cancer Res. 44:1405-1408.

Shrestha, K., R.N. Hiramoto and V.K. Ghanta. 1984. Regulation of MOPC 104E by T-cell and growth factors induced by C. parvum stimulation. Int. J. Cancer 33:845-850.

Hiramoto, R., P. Cox, N.S. Hiramoto and V. Ghanta. 1984. Inhibition of growth of MOPC 104E cells in immunosuppressed mice. J. Immunol. 133:3424.

Evanochko, W.T., T.T. Sakai, T.C. Ng, N.R. Krishna, H.D. Kim, R.B. Zeidler, V.K. Ghanta, W.R. Brockman, L.M. Schiffer, P.G. Braunschweiger and J.R. Glickson. 1984. NMR studies of in vivo RIF-1 tumors: Analysis of perchloric acid extracts and identification of 1H, 31P, and 13C resonances. Biochim. Biophy. Acta 805:104-116.

Hiramoto, R.N., V.K. Ghanta and S-J. Soong. 1985. Tumor burden, chemotherapy and cell kill in osteosarcoma model. Amer. J. Clin. Oncol. 8:89.

Ghanta, V.K., P.J. Cox, N.S. Hiramoto, W.B. Mills, H.J. Cohen and R.N. Hiramoto. 1985. Host regulation of MOPC 104E plasmacytoma after reduction of tumor burden by total body irradiation. Cancer Inv. 3:217.

Shrestha, K., R.N. Hiramoto and V.K. Ghanta. 1985. Establishment of growth factor-dependent MOPC 104E cell line in vitro. Cell. Immunol. 90:24.

Ghanta, V., R. Hiramoto, B. Solvason and H. Spector. 1985. Neural and environmental influences on neoplasia and conditioning of NK activity. J. Immunol. 135:848S.

Kodama, K., V. Ghanta, R.N. Hiramoto, R.S. Stohrer and J.F. Kearney. 1986. In vitro effect of monoclonal anti-idiotype antibodies (anti-M104E) on MOPC 104E myeloma cells. Cancer Res. 46:1250.

Ghanta, V., K. Shrestha and R. Hiramoto. 1986. Induction of the plateau phase and rescue of MOPC 104E by non-specific immunization. Cancer Invest. 4:525-533.

Dean, D., R. Hiramoto and V. Ghanta. 1987. Ischemic injury of submadibular glands. J. Oral Med. 42:125.

Ghanta, V., N.S. Hiramoto, H.B. Solvason, S.K. Tyring, N.H. Spector, N.H. and R.N. Hiramoto. 1987. Conditioned enhancement of natural killer cell activity, but not interferon, with camphor or saccharin-LiCl conditioned stimulus. J. Neurosci. Res. 18:10-15.

Hiramoto, R.N., N.S. Hiramoto, H.B. Solvason and V.K. Ghanta. 1987. Regulation of natural immunity (NK activity) by conditioning. Ann. N.Y. Acad. Sci., 496:545-552.

Ghanta, V., R.N. Hiramoto, B. Solvason and N.H. Spector. 1987. Influence of conditioned natural immunity on tumor growth. Ann. N.Y. Acad. Sci. 496:637.

Solvason, H.B., Brent, V. Ghanta and R. Hiramoto. 1988. Conditioned augmentation of natural killer cell activity: independence from nociceptive effects and dependence on b-interferon. J. Immunol. 140:661.

Tyring, S.K., R. Cauda, V.K. Ghanta and R.N. Hiramoto. 1988. Activation of natural killer cell function during interferon.a treatment of patients with condyloma acuminatum is predictive of clinical response. J. Biol. Regul. Homeost. Agents II:29-31.

Miura, T., V. Ghanta and R. Hiramoto, R. 1988. Host response to myeloma: I. Induction of cytotoxic and suppressor T cells by in vivo immunization with MOPC 104E plasmacytoma. Cancer Invest. 6:29-37.

Ghanta, V., T. Miura, N. Hiramoto, N. and R. Hiramoto. 1988. Augmentation of natural immunity and regulation of tumor growth by conditioning. Ann. N.Y. Acad. Sci. 521:29.

Hayashida, I., R.N. Hiramoto, K. Shrestha and V.K. Ghanta. 1989. Immunoregulation of murine plasmaycotma I. Generation of anomalous killer cells in vitro by co-cultivation with MOPC 104E. Cancer Invest. 7(1):27-39.

Hayashida, I., R.N. Hiramoto, K. Shrestha and V.K. Ghanta. 1989. Immunoregulation of murine plasmacytoma II. Target selectivity of anomalous killer cells and role immune T-cells for the induction. Cancer Invest. 7(1):17-26.

Kodama, K., V.K. Ghanta, N.S. Hiramoto and R.N. Hiramoto. 1989. Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies. J. Biol. Resp. Mod. 8:385-396.

Solvason, H. B., R.N. Hiramoto and V.K. Ghanta. 1989. Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB/c mice. Brain Behav. Immunity 3(3):247-262.

Ghanta, V. K., R.N. Hiramoto, C.A. Parker, V.J. Kidd and M.G. Humphrey-Beher. 1989. In Vitro and In Vivo Growth Control of Transformed Lymphoid Cells Expressing Plasma Membrane B1-4 Galactosyltransferase. Oncogene 4:1337-1344.

Miura, T., V.K. Ghanta and R.N. Hiramoto. 1990. Host response to myeloma: Effect of syngeneic spleen cells on the growth and function of MOPC 104E myeloma cells in vitro. Cancer Invest. 8(1):17-25.

Hiramoto, R.N., B. Solvason, V. Ghanta, J. Lorden and N. Hiramoto. 1990. Effect of Reserpine on Retention of the Conditioned NK Cell Response. Pharmacol. Biochem. Behav. 36:51-56.

Ghanta, V., N. Hiramoto and R.N. Hiramoto. 1990. Thymic peptides as anti-aging drugs: Effect of thymic hormones on immunity and lifespan. Int. J. Neurosci. 31:119-120.

Sawamura, M., M.P. Everson, K. Shrestha, V.K. Ghanta, D.M. Miller, R.N. Hiramoto. 1990. Characterization of 5B12.1, a monoclonal antibody specific for IL-6. Growth Factors 3:181-190.

Ghanta, V.K., N.S. Hiramoto, H.B. Solvason, S-J. Soong and R.N. Hiramoto. 1990. Conditioning: a new approach to immunotherapy. Cancer Res. 50:4295-4299.

Ghanta, V.K., N.S. Hiramoto, S-J. Soong and R.N. Hiramoto. 1990. Survey of thymic hormone effects on physical and Immunological parameters in C57BL/6NNia mice of different ages. Ann. New York Acad. Sci. 621:239-251.

Ghanta, V., N. Hiramoto, S-J. Soong and R. Hiramoto. 1991. Effect of thymic hormone treatment on several immune functions of nude mice. Mech. Aging Dev. 58:245-254.

Hiramoto, R.N., V.K. Ghanta, C. Rogers and N. Hiramoto. 1991. Conditioning Fever: A Host Defensive Reflex Response. Life Sci. 49:93-99.

Ghanta, V.K., C.F. Rogers, C-M. Hsueh, N. Hiramoto, S-J. Soong and R.N. Hiramoto. 1991. In Vivo enhancement of NK cell activity with met-enkephalin and glycyl-glutamine: Their possible role in the conditioned response. Int. J. Neurosci. 61:135-143.

Solvason, H.B., V.K. Ghanta, J.F. Lorden, S-J. Soong and R.N. Hiramoto. 1991. A behavioral augmentation of natural immunity: Odor specificity supports a Pavlovian conditioning model. Int. J. Neurosci. 61:277-288.

Hiramoto, R.N., N.S. Hiramoto, M.E. Rish, S-J. Soong, D.M. Miller and V. Ghanta. 1991. Role of immune cells in the Pavlovian conditioning of specific resistance to cancer. Int. J. Neurosci. 59:101-117.

Solvason, H.B., V.K. Ghanta, S-J. Soong and R.N. Hiramoto. 1991. Interferon interaction with the CNS is required for the conditioning of the NK cell response. Prog. NeuroendocrinImmunol. 4:258-264.

Solvason, H.B., V.K. Ghanta, S-J. Soong, C.F. Rogers, C-M. Hsueh, N. Hiramoto and R. Hiramoto. 1992. A simple single trial learning paradigm to condition the natural killer cell activity. Proc. Soc. Exp. Biol. Med. 199:199-203.

Hiramoto, R.N., V.K. Ghanta, J.F. Lorden, H.B. Solvason, S-J. Soong, C.F. Rogers, C-M. Hsueh and N.S. Hiramoto. 1992. Conditioning of the NK cell response: Effects of interstimulus intervals and evidence from long delayed learning. Prog. NeuroendocrinImmunol. 5:13-20.

Hsueh, C-M., R.N. Hiramoto and V.K. Ghanta. 1992. The central effect of methionine-enkephalin on NK cell activity. Brain Res. 578:142-148.

Rogers, C., V. Ghanta, C-M. Hsueh, N. Hiramoto and R. Hiramoto. 1992. Indomethacin and sodium carbonate effects on conditioned fever and NK cell activity. Pharmacol. Biochem. Behav. 43:417-422.

Hsueh, C-M., J.F. Lorden, R.N. Hiramoto and V.K. Ghanta. 1992. Acquisition of enhanced natural killer cell activity under anesthesia. Life Sci. 50:2067-2074.

Hiramoto, R.N., V.K. Ghanta, H.B. Solvason, J.F. Lorden, C-M. Hsueh, C.F. Rogers, S. Demissie and N.S. Hiramoto. 1993. Identification of specific pathways of communication between the CNS and NK cell system. Life Sci. 53:527-540.

Hsueh C-M, R.N. Hiramoto and V.K. Ghanta. 1994. Efferent signal(s) responsible for the conditioned augmentation of natural killer cell activity. Neuroimmunomodulation 1:74-81.

Rogers, C., V. Ghanta, V., C-M. Hsueh, N. Hiramoto and R. Hiramoto. 1992. The direction of the conditioned NK cell response can be redirected with indomethacin and/or handling. Int. J. Neurosci. 67:229-239.

Hiramoto, R.N., C-M. Hsueh, C.F. Rogers, S. Demissie, N.S. Hiramoto, S-J. Soong and V.K. Ghanta. 1993. Conditioning of the allogeneic cytotoxic lymphocyte response. Pharmacol. Biochem. Behav. 44:275-280.

Ghanta, V.K., N. Hiramoto, S-J. Soong, D. Miller and R. Hiramoto. 1993. A multiple modality approach combining the effect of conditioning with adoptive chemoimmunotherapy. Int. J. Neurosci. 71:251-265.

Solvason, H.B., V.K. Ghanta and R.N. Hiramoto. 1993. The identity of the unconditioned stimulus to the CNS is interferon-beta. J. Neuroimmunology 45:75-82.

Hiramoto, R.N., V.K. Ghanta, S-J. Soong and N.S. Hiramoto. 1994. Use of an allogeneic antigen to induce resistance and regression of an autologous tumor. J. Immunother. 15:202-211.

Ghanta V.K., C.F. Rogers, C-M. Hsueh, S. Demissie, N.S. Hiramoto and R.N. Hiramoto. 1994. Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and US. J. Neuroimmunol. 50:109-114.

Rogers C.F., V.K. Ghanta, S. Demissie, N.S. Hiramoto and R.N. Hiramoto. 1994. Lidocaine interrupts the conditioned natural killer cell response. Neuroimmunomodulation 1:278-283.

Rogers C., V. Ghanta, S. Demissie, N. Hiramoto and R.N. Hiramoto. 1994. Sodium carbonate prevents NK cell conditioning by interfering with the US signal. Intern. J. Neurosci. 77:277-286.

Kerr M., J.E. Fischer, K.R. Purushotham, D. Gao, Y. Nakagawa, N. Maeda, V. Ghanta, R. Hiramoto, N. Chegini and M.G. Humphreys-Beher. 1994. Characterization of the synthesis and expression of the GTA-kinase from transformed and normal rodent cells. Biochim. Biophys. Acta 1218:375-387.

Hsueh, C-M., C.F. Rogers, R.N. Hiramoto and V.K. Ghanta. 1994. Effect of dexamethasone on conditioned enhancement of NK cell activity. Neuroimmunomodulation 1:370-376.

Ghanta V.K., H.B. Solvason, N.S. Hiramoto, J.F. Lorden and R.N. Hiramoto. 1994. Depletion of brain catecholamines interferes with camphor odor conditioning. Life Sci. Adv.- Allergy and Immunology 13: 53-57.

Hsueh, C-M., S-F. Chen, V.K. Ghanta and R.N. Hiramoto. 1995. Expression of the conditioned NK cell activity is beta-endorphin dependent. Brain Res. 678:76-82.

Ghanta V.K., N.S. Hiramoto, S-J. Soong and R.N. Hiramoto RN. 1995. Conditioning of the Secondary T-lymphocyte response to YC8 tumor. Pharmacol. Biochem. Behav. 50: 399-403.

Demissie, S., C.F. Rogers, N.S. Hiramoto, V.K. Ghanta and R.N. Hiramoto. 1995. Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity. J. Neuroimmunol. 59:57-63.

Demissie S., C.F. Rogers, N.S. Hiramoto, V.K. Ghanta and R.N. Hiramoto. 1996. Lipopolysaccharide and IL-1 activate CNS pathways as measured by NK cell activity. Physiol. Behav. 59:499-504.

Hiramoto, R., C. Rogers, S. Demissie, C-M. Hsueh, N. Hiramoto, J. Lorden and V. Ghanta. 1996. The use of conditioning to probe for pathways linking multiple conditioned responses: Fever and NK cell activity. Int. J. Neurosci. 84:229-245.

Hsueh, C-M., S-F. Chen, H-J. Huang, V.K. Ghanta and R.N. Hiramoto, RN. 1996. Activation of the µ-opioid receptors are required for the conditioned enhancement of NK cell activity. Brain Res. 737:263-268.

Hsueh, C-M., S-F. Chen, V.K. Ghanta and R.N. Hiramoto. 1996. Involvement of cytokine gene expression in the age-dependent decline of NK cell response. Cell. Immunol. 173:221-229.

Ghanta, V., S. Demissie, N. Hiramoto and R. Hiramoto. 1996. Conditioning of body temperature and NK cell activity with arecoline a muscarinic cholinergic agonist. Neuroimmunomodulation 3:233-238.

Hiramoto, R., C-M. Hsueh, S. Demissie, C. Rogers, J. Lorden and V. Ghanta. 1997. Psychoneuroendocrineimmunology: Site of recognition, learning, and memory in the immune system and the brain (Review). Int. J. Neurosci. 92:259-286.

Demissie, S., E. Ban, C. Rogers, N. Hiramoto, V. Ghanta and R. Hiramoto. Afferent signals to the CNS appear not to condition the modulation of IL-1 receptors in the hippocampus. Neuroimmunomodulation. In press.

Hiramoto, R., B. Solvason, C-M. Hsueh, C. Rogers, S. Demissie, N. Hiramoto,D. Gauthier, J. Lorden and V. Ghanta. 1999. Psychoneuroendocrine Immunology: Perception of stress can alter body temperature and natural killer cell activity (Review). International Journal of Neuroscience 98:95-129.

Demissie, S., V. Ghanta, N. Hiramoto, R. Hiramoto. 2000. NK cell and CTL activities can be raised via conditioning of the CNS with unrelated unconditioned stimuli. International Journal of Neuroscience 103:79-89.

Ghanta, V., N. Hiramoto, G. Yancey Gillespie, Dorothy K. Gauthier and R. Hiramoto. 2000. Immunotherapy of murine T cell lymphoma localized to the brain. Journal of Neuro-Oncology 47:1-10.

Hale, K., V. Ghanta, D. Gauthier and R. Hiramoto. 2001. Effects of rotational stress of different durations on NK cell activity, proinflammatory cytokines, and POMC-derived peptides in mice. Neuroimmunomodulation 9:34-40.

Hale, K., D. Weigent, D. Gauthier, R. Hiramoto and V. Ghanta. 2003. Cytokine and hormone profiles in mice subjected to handling combined with rectal temperature measurement stress and handling only stress. Life Science 72:1495-1508.

Back to Ghanta Home Page